EP Patent

EP1365808B1 — Compositions for antitumour treatment containing ecteinascidin 743

Assigned to Pharmamar SA · Expires 2011-01-19 · 15y expired

What this patent protects

ET-743 is used in the preparation of a medicament for an effective treatment of a tumour by combination therapy employing ET-743 with another drug.

USPTO Abstract

ET-743 is used in the preparation of a medicament for an effective treatment of a tumour by combination therapy employing ET-743 with another drug.

Drugs covered by this patent

Patent Metadata

Patent number
EP1365808B1
Jurisdiction
EP
Classification
—
Expires
2011-01-19
Drug substance claim
No
Drug product claim
No
Assignee
Pharmamar SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.